Our Pricing

Aciclovir & Cold Sore Treatment During Pregnancy

Published on: June 03, 2026

Concerned about aciclovir pregnancy uk safety? Cold sores during pregnancy are common, and aciclovir remains the most widely prescribed antiviral treatment in the UK. At Cured Pharmacy, our UK clinical team provides evidence-based guidance to help you manage cold sores safely throughout pregnancy, with transparent pricing and discreet delivery of UK-licensed treatments.

Is Aciclovir Safe During Pregnancy?

Aciclovir has been used extensively in pregnancy for over three decades, with substantial safety data supporting its use when clinically indicated [1]. The medication works by inhibiting viral DNA replication specifically in infected cells, without interfering with normal human cell function. This targeted mechanism contributes to its favourable safety profile.

Large observational studies, including the Aciclovir in Pregnancy Registry which monitored over 1,200 exposures, found no increased risk of birth defects compared to the general population [1][2]. The UK Medicines and Healthcare products Regulatory Agency (MHRA) classifies aciclovir as suitable for use during pregnancy when the potential benefit outweighs any theoretical risk, particularly for managing recurrent herpes simplex infections.

Topical aciclovir cream, such as our Numark Cold Sore Cream available from £4.49, involves minimal systemic absorption — typically less than 5% reaches the bloodstream [3]. This makes topical formulations particularly reassuring for pregnant patients concerned about foetal exposure. Oral aciclovir tablets may be prescribed by UK clinicians for more severe or frequent outbreaks, always following individual clinical assessment.

Cold Sore Treatment Options While Pregnant

Pregnancy doesn't limit your treatment options as much as you might think. Topical aciclovir cream remains the first-line recommendation for localised cold sores, applied at the first tingling sensation to reduce outbreak severity and duration [4]. The cream should be applied five times daily for five days, though some patients find four-hourly application during waking hours more practical.

For women experiencing frequent recurrences — typically defined as six or more outbreaks annually — UK prescribers may recommend oral aciclovir suppressive therapy during the third trimester. This approach has been particularly well-studied in pregnant women with genital herpes, where it significantly reduces the risk of viral shedding at delivery [2][4]. The same principles apply to oral herpes management when outbreaks are frequent or severe enough to impact nutrition or hydration.

Non-Pharmacological Management Strategies

Alongside antiviral treatment, several evidence-based strategies can reduce outbreak frequency and severity during pregnancy. Avoiding known triggers such as excessive sun exposure, stress, and fatigue becomes particularly important when hormonal changes may already increase susceptibility. Using a high-SPF lip balm with UV protection can prevent sun-triggered outbreaks, whilst maintaining adequate rest and nutrition supports immune function.

Cold compresses applied to active lesions can provide symptomatic relief without any safety concerns. Keeping the affected area clean and dry promotes healing, whilst avoiding touching or picking at lesions reduces the risk of bacterial superinfection and transmission to other body sites or individuals.

Aciclovir Cream vs Tablets: Which Is Right for You?

The choice between topical and oral aciclovir during pregnancy depends on outbreak frequency, severity, and timing. Topical aciclovir cream works best when applied at the prodromal stage — that characteristic tingling or burning sensation before visible blisters appear. Studies show that early application can reduce healing time by approximately 1-2 days and may prevent full blister development in some cases [3][4].

Oral aciclovir tablets offer systemic antiviral coverage and are typically reserved for more extensive outbreaks, frequent recurrences, or suppressive therapy in late pregnancy. The standard treatment dose is 200mg five times daily for five days, though dosing may be adjusted based on individual clinical factors. Suppressive therapy typically uses 400mg twice daily from 36 weeks gestation until delivery for women with recurrent genital herpes, a protocol that can be adapted for severe oral herpes under specialist guidance [2].

When to Escalate Treatment

Certain situations warrant consideration of oral rather than topical therapy during pregnancy. If you're experiencing outbreaks monthly or more frequently, if lesions are particularly extensive or painful, or if topical treatment hasn't provided adequate control in previous outbreaks, discuss oral aciclovir with your UK prescriber. Women who are immunocompromised or have eczema herpeticum require specialist assessment and may need intravenous aciclovir in hospital settings.

It's also worth noting that whilst topical treatment addresses localised symptoms, it doesn't reduce viral shedding as effectively as oral therapy. For women concerned about transmission to their baby during delivery — though oral herpes poses minimal risk compared to genital herpes — oral suppressive therapy in late pregnancy may offer additional reassurance following clinical consultation.

Understanding Cold Sore Triggers in Pregnancy

Pregnancy creates a unique immunological state that can increase susceptibility to herpes simplex virus reactivation. The physiological shift towards Th2-dominant immunity, necessary to prevent foetal rejection, may reduce the body's ability to suppress latent viral infections [5]. This partly explains why some women experience their first cold sore during pregnancy, or notice increased frequency if they've had previous outbreaks.

Hormonal fluctuations, particularly the dramatic rise in progesterone and oestrogen, can trigger reactivation in women with established HSV-1 infection. Fatigue and stress — both common in pregnancy — further compromise immune surveillance. First-trimester nausea and dietary changes may also deplete nutrients important for immune function, such as lysine, zinc, and B vitamins.

Recognising your personal triggers becomes particularly valuable during pregnancy. Many women notice patterns: outbreaks following poor sleep, during periods of high stress, or after sun exposure. Keeping a brief symptom diary can help identify your triggers and inform preventative strategies. If outbreaks consistently coincide with specific pregnancy milestones or stressors, discuss this pattern with your UK prescriber — it may influence whether suppressive therapy is appropriate.

Aciclovir Pregnancy UK Safety: What the Research Shows

The evidence base for aciclovir pregnancy uk safety is more robust than for most medications used during pregnancy. The Aciclovir in Pregnancy Registry, established in 1984 and closed in 1999 after accumulating extensive data, found birth defect rates of 2.2% among first-trimester exposures — comparable to the 2-3% baseline rate in the general population [1]. Subsequent population-based studies from Denmark and the UK have reinforced these findings with even larger cohorts.

A 2010 Danish nationwide cohort study examined 1,804 pregnancies with first-trimester aciclovir exposure and found no increased risk of major birth defects, preterm birth, or low birth weight [6]. The study's size and population-based design provide particularly reliable evidence, as it captured all prescriptions dispensed rather than relying on voluntary reporting. Similar reassuring data exist for use in later trimesters.

Importantly, aciclovir is not associated with the specific organ malformations that characterise truly teratogenic medications. The theoretical concern with any antiviral is interference with rapidly dividing cells, but aciclovir's selective activation only in virally-infected cells minimises this risk. The UK Teratology Information Service (UKTIS) and the British National Formulary both support aciclovir use during pregnancy when clinically appropriate, reinforcing its position as the safest evidence-based option for herpes simplex management.

Third Trimester Considerations

Late pregnancy aciclovir use has been particularly well-studied due to its role in preventing neonatal herpes transmission. Women with recurrent genital herpes often receive suppressive aciclovir from 36 weeks until delivery, a practice supported by multiple randomised controlled trials showing reduced viral shedding and caesarean section rates [2][4]. Whilst oral cold sores pose minimal transmission risk to newborns compared to genital lesions, the safety data from third-trimester use is nonetheless reassuring for any indication.

If you develop a cold sore close to your due date, prompt treatment with aciclovir cream remains appropriate. The main precaution is avoiding direct contact between active lesions and your newborn after delivery, as neonatal herpes — though rare from oral lesions — can be serious. Simple measures like hand hygiene, avoiding kissing the baby while lesions are active, and covering lesions when holding your infant are sufficient protective strategies.

How to Use Aciclovir Safely During Pregnancy

Optimal results with topical aciclovir depend on early application and consistent dosing. At the first sign of tingling, burning, or itching — typically 6-24 hours before blisters appear — apply a thin layer of cream to the affected area and surrounding skin. The standard regimen is five applications daily, approximately four hours apart during waking hours, continued for five days even if lesions heal earlier [3].

Wash your hands thoroughly before and after application to prevent viral spread to other body sites or individuals. Avoid sharing towels, lip balms, or eating utensils during active outbreaks. If you're using other topical products on your face, apply aciclovir cream last to ensure maximum contact with the affected area. The cream may cause mild transient stinging, but this typically resolves within minutes.

For oral aciclovir tablets prescribed during pregnancy, take doses at evenly spaced intervals with a full glass of water. The medication can be taken with or without food, though taking it with meals may reduce any mild gastrointestinal side effects. Maintaining good hydration is particularly important with oral aciclovir to support kidney function — aim for at least eight glasses of water daily unless your midwife has advised fluid restriction for other reasons.

When to Seek Medical Advice

Most cold sores during pregnancy resolve without complications, but certain situations require prompt medical assessment. Contact your GP or midwife if lesions haven't begun healing within seven days of starting treatment, if you develop fever or feel systemically unwell, or if the outbreak is unusually extensive or painful. These features may indicate secondary bacterial infection or, rarely, more severe herpes simplex disease requiring specialist input.

First-time cold sore outbreaks during pregnancy warrant medical review to confirm the diagnosis and rule out other causes of oral lesions. If you're in your third trimester and develop genital lesions alongside oral cold sores, contact your maternity team promptly, as this may influence delivery planning. Women who are immunocompromised should always seek medical advice before self-treating cold sores, as they may require higher doses or intravenous therapy.

Scientific References

1. Stone, K. M., et al. (2004). Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Research Part A: Clinical and Molecular Teratology, 70(4), 201–207. https://doi.org/10.1002/bdra.20013 [accessed 13 August 2026]
2. Sheffield, J. S., et al. (2003). Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: A systematic review. Obstetrics & Gynecology, 102(6), 1396–1403. https://doi.org/10.1016/j.obstetgynecol.2003.08.015 [accessed 13 August 2026]
3. Spruance, S. L., et al. (2002). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 185(9), 1211–1218. https://doi.org/10.1086/340041 [accessed 13 August 2026]
4. Hollier, L. M., & Wendel, G. D. (2008). Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews, (1), CD004946. https://doi.org/10.1002/14651858.CD004946.pub2 [accessed 13 August 2026]
5. Kourtis, A. P., et al. (2014). Pregnancy and infection. New England Journal of Medicine, 370(23), 2211–2218. https://doi.org/10.1056/NEJMra1213566 [accessed 13 August 2026]
6. Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA, 304(8), 859–866. https://doi.org/10.1001/jama.2010.1206 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication during pregnancy.